Personalisation of healthcare is a driver of innovation in research, healthcare systems and industry. Policy makers, healthcare professionals, citizens, and private companies need proper advice to realize its potential. The Personalized pREvention of Chronic DIseases consortium (PRECeDI) is a Marie Skłodowska Curie Action (MSCA) project funded within the Research and Innovation Staff Exchange (RISE) scheme that aimed at providing high-quality, multidisciplinary knowledge through training and research in Personalized Medicine (PM), with specific reference to personalized prevention of chronic diseases. PM approaches are already being implemented especially in the fields of disease diagnosis and treatment with the use of biomarkers, however, development and implementation of such approaches for chronic disease prevention needs further investigation and concerted efforts for proper implementation in healthcare systems.
Boccia, Stefania and Ricciardi, Walter and Pastorino, Roberta and Ádány, Rósa and Barnhoorn, Floris and Boffetta, Paolo and Boretti, Franco and Cornel, Martina and De Vito, Corrado and Gray, Muir and Jani, Anant and Lang, Michael and Paglione, Marcello and Roldan, Jim and Rosso, Annalisa and Sánchez, José Manuel and Van Dujin, Cornelia and Van El, Carla and Villari, Paolo and Zawati, Ma'n H., How to Integrate Personalized Medicine Into Prevention? Recommendations From the Personalized pREvention of Chronic Diseases (PRECeDI) Consortium (November 14, 2018). Personalzed PREvention of Chronic Diseases (PRECeDI), 2018 , Available at SSRN: https://ssrn.com/abstract=3289638
Subscribe to this fee journal for more curated articles on this topic
FOLLOWERS
54
PAPERS
1,900
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.